Home › Research › Topics › akkermansia-muciniphila
akkermansia-muciniphila
2 studies tagged akkermansia-muciniphila, dated 2022-03-11 to 2025-01-20. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer's disease pathologic process via GPR41 and GPR43 2025-01-20
- The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential 2022-03-11
Studies
2 studies carry this tag.
Date range
2022 to 2025
Top journals
- Critical reviews in microbiology 1
- Microbiome 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Our results demonstrate that A. muciniphila and its metabolite propionate protect against AD-like pathological events in AD mouse models by targeting mitochondrial homeostasis, making them promising therapeutic candidates for the prevention and treatment of AD.
-
The role of Akkermansia muciniphila , one of the most abundant microorganisms of the intestinal microbiota, has been studied extensively in metabolic diseases, such as obesity and diabetes.